Your browser doesn't support javascript.
loading
Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi, Laura A; Millar, Amanda; Tolson, Elissa; Singleton, Matthew; Hassall, Emily; Kojic, Marija; Brighi, Caterina; Girard, Emily; Andradas, Clara; Kuchibhotla, Mani; Bhuva, Dharmesh D; Endersby, Raelene; Gottardo, Nicholas G; Bernard, Anne; Adolphe, Christelle; Olson, James M; Taylor, Michael D; Davis, Melissa J; Wainwright, Brandon J.
Afiliación
  • Genovesi LA; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Millar A; Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Tolson E; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Singleton M; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Hassall E; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Kojic M; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Brighi C; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Girard E; ARC Centre of Excellence for Convergent Bio-Nano Science and Technology, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Andradas C; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Kuchibhotla M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  • Bhuva DD; Brain Tumour Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA, 6009, Australia.
  • Endersby R; Brain Tumour Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA, 6009, Australia.
  • Gottardo NG; Bioinformatics Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, 3052, Australia.
  • Bernard A; Department of Medical Biology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, Victoria, 3010, Australia.
  • Adolphe C; Brain Tumour Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA, 6009, Australia.
  • Olson JM; Brain Tumour Research Program, Telethon Kids Cancer Centre, Telethon Kids Institute, Nedlands, WA, 6009, Australia.
  • Taylor MD; QFAB Bioinformatics, Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD, 4072, Australia.
  • Davis MJ; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD, 4102, Australia.
  • Wainwright BJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
Genome Med ; 13(1): 103, 2021 06 21.
Article en En | MEDLINE | ID: mdl-34154646
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacogenética / Biomarcadores de Tumor / Neoplasias Cerebelosas / Desarrollo de Medicamentos / Meduloblastoma / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Farmacogenética / Biomarcadores de Tumor / Neoplasias Cerebelosas / Desarrollo de Medicamentos / Meduloblastoma / Antineoplásicos Tipo de estudio: Guideline / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Genome Med Año: 2021 Tipo del documento: Article País de afiliación: Australia